.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Treatment Advances for Advanced Melanoma

EP. 1: Management of Locally Advanced Melanoma

November 30th 2018

EP. 2: Completion Lymph Node Dissection in Melanoma

November 30th 2018

EP. 3: Molecular Testing for Stage III Melanoma

November 30th 2018

EP. 4: Adjuvant Therapy in Melanoma: COMBI-AD Trial

November 30th 2018

EP. 5: Anti-PD-1 Adjuvant Therapy in Melanoma

November 30th 2018

EP. 6: Adjuvant Therapy in Melanoma: Targeted vs Immuno-Oncology

November 30th 2018

EP. 7: Role of Neoadjuvant Therapy for Melanoma

November 30th 2018

EP. 8: Anti-PD-1 Therapy in Metastatic Melanoma

November 30th 2018

EP. 9: Combination Ipilimumab/Nivolumab in Metastatic Melanoma

November 30th 2018

EP. 10: BRAF/MEK Inhibitors in Metastatic Melanoma

November 30th 2018

EP. 11: Managing Brain Mets in Melanoma

November 30th 2018

EP. 12: Intralesional Therapy in Metastatic Melanoma

November 30th 2018

EP. 13: Emerging Combination Therapies in Advanced Melanoma

November 30th 2018

EP. 14: Emerging Triplet Regimens in Advanced Melanoma

November 30th 2018

EP. 15: Future Outlook: Treating Advanced Melanoma

November 30th 2018